Last update:

Clinical pharmacology news

First-in-class molecules dial down inflammation without compromising immunity

Scripps Research scientists have developed a new class of drug compounds that reduce harmful inflammation while leaving the body's ability to fight infections intact—a long-sought goal in treating autoimmune diseases. The ...

This is your brain on psychedelics: Neuroimaging study sheds light on cortical network effects

Psychedelic drugs are being investigated as scientific and clinical tools, but the brain mechanisms behind their effects remain unclear. Earlier brain imaging studies in small cohorts from single centers produced inconsistent ...

Zebrafish reveal new insights into the biology of autism

In recent decades, the zebrafish has become one of the most valuable model organisms in scientific research. For a variety of reasons, including their genetic similarities to humans, these tiny tropical fish have helped researchers ...

FDA approves new weight loss pill in record time

A new daily pill to help with weight loss has been approved by the U.S. Food and Drug Administration (FDA), and it moved through review faster than most drugs in recent years.

New pill could change plaque psoriasis treatment

Folks with severe plaque psoriasis often have to choose between convenient pills that don't work very well or highly effective injections that come with the hassle of needles. That trade-off may soon change. New clinical ...

Poison centers see jump in kava calls

Calls to poison centers about kava—a drug found in drinks marketed as a healthy alternative to alcoholic beverages—rose 383% between 2011 and 2025, according to a new UVA Health study. The findings have been published in ...

Probing a paradoxical drug response for irregular heartbeat

Irregular heartbeat, or arrhythmia, can be treated with various procedures or medication, but not all medications work for all patients. In fact, one arrhythmia medication can actually cause arrhythmia in people with a common ...

Mirror fragments intercept Alzheimer's-causing protein

Understanding how proteins interact with their own mirror images enabled a Kobe University research team to design a small mirror protein that disables a causal factor of Alzheimer's disease, amyloid-beta.

Common antidepressant may ease long COVID fatigue

A randomized clinical trial found that the antidepressant fluvoxamine significantly reduces long COVID-related fatigue, one of the condition's most persistent and debilitating symptoms, while the diabetes drug metformin showed ...

Brain wiring model could shorten path to new medicines

A new, more life-like physical model of microscopic nerve fibers called axons could speed up the discovery of medicines for multiple sclerosis and other degenerative brain diseases, suggests a new study led by UCL researchers. ...

Q&A: Should you trust trending peptide injections?

If you could inject yourself with a substance that purports to make you tanner, fitter, and healthier, would you? Many people are saying "yes." Online, social media influencers tout vials of substances with names like BPC-157 ...

FDA warns biotech firm over cancer drug claims

The U.S. Food and Drug Administration (FDA) has warned a biotech company about claims that its bladder cancer drug could treat and prevent multiple types of cancer.